EcoDrugPlus

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSPTIG00000013400
Gene Symbol: MTOR
2 Cross references
214 Possible Orthologues:

Melanocortin 3 Receptor

Ensembl ID : ENSPTIG00000001341
Gene Symbol: MC3R
2 Cross references
138 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSPTIG00000000125
Gene Symbol: MC4R
2 Cross references
121 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSPTIG00000013070
Gene Symbol: MTNR1A
1 Cross references
205 Possible Orthologues:

Melatonin Receptor 1b

Ensembl ID : ENSPTIG00000018222
Gene Symbol: MTNR1B
2 Cross references
107 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSPTIG00000016196
Gene Symbol: MME
2 Cross references
231 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSPTIG00000021175
Gene Symbol: METAP2
2 Cross references
212 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSPTIG00000007151
Gene Symbol: MAPK1
1 Cross references
213 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSPTIG00000019645
Gene Symbol: MAPK10
2 Cross references
147 Possible Orthologues:

Mitogen-Activated Protein Kinase 11

Ensembl ID : ENSPTIG00000001133
Gene Symbol: MAPK11
2 Cross references
200 Possible Orthologues:

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSPTIG00000011843
Gene Symbol: MAPK14
2 Cross references
280 Possible Orthologues:

Mitogen-Activated Protein Kinase 3

Ensembl ID : ENSPTIG00000019078
Gene Symbol: MAPK3
2 Cross references
198 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).